Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cannom

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
Pacing and Clinical Electrophysiology : PACE|June 24, 2009
The role of electrophysiologic studies in dilated cardiomyopathy: definitive results from the DEFINITE trialBrett Gidney, David S Cannom
Journal of the American College of Cardiology|August 2, 2014
Neither too fast nor too hot: keeping marathoners' hearts alive during the raceBrian Olshansky, David S Cannom
Circulation|June 15, 2007
Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devicesRobert A Kloner, David S Cannom
JAMA|January 23, 1999
Management of ventricular arrhythmias: detection, drugs, and devicesD S Cannom, E N Prystowsky
Current Opinion in Cardiology|January 1, 1996
Implantable cardioverter-defibrillator advancesR D Lerman, D S Cannom
Expert Opinion on Pharmacotherapy|April 15, 2009
Methylnaltrexone: the answer to opioid-induced constipation?Rebecca R Cannom, Rodney J Mason
Journal of the American College of Cardiology|May 5, 2022
Cardiac Arrest and Sudden Death: Establishing the Need for Focusing on Prehospital and In-Hospital CareDavid G Benditt, David S Cannom
Journal of Cardiovascular Electrophysiology|January 24, 2006
Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society membersRachel Lampert, David Cannom, Brian Olshansky
Cardiac Electrophysiology Review|May 27, 2003
New device indications: impact on the individual electrophysiology (EP) practitioner in a predominantly managed care environmentMary Rose Patejak, David S Cannom
Heart Rhythm|April 11, 2013
The evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
Pacing and Clinical Electrophysiology : PACE|June 24, 2009
The role of electrophysiologic studies in dilated cardiomyopathy: definitive results from the DEFINITE trialBrett Gidney, David S Cannom
Journal of the American College of Cardiology|August 2, 2014
Neither too fast nor too hot: keeping marathoners' hearts alive during the raceBrian Olshansky, David S Cannom
Circulation|June 15, 2007
Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devicesRobert A Kloner, David S Cannom
JAMA|January 23, 1999
Management of ventricular arrhythmias: detection, drugs, and devicesD S Cannom, E N Prystowsky
Current Opinion in Cardiology|January 1, 1996
Implantable cardioverter-defibrillator advancesR D Lerman, D S Cannom
Expert Opinion on Pharmacotherapy|April 15, 2009
Methylnaltrexone: the answer to opioid-induced constipation?Rebecca R Cannom, Rodney J Mason
Journal of the American College of Cardiology|May 5, 2022
Cardiac Arrest and Sudden Death: Establishing the Need for Focusing on Prehospital and In-Hospital CareDavid G Benditt, David S Cannom
Journal of Cardiovascular Electrophysiology|January 24, 2006
Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society membersRachel Lampert, David Cannom, Brian Olshansky
Cardiac Electrophysiology Review|May 27, 2003
New device indications: impact on the individual electrophysiology (EP) practitioner in a predominantly managed care environmentMary Rose Patejak, David S Cannom
Heart Rhythm|April 11, 2013
The evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Pageof 18